149 related articles for article (PubMed ID: 11829281)
1. Adjuvant therapy of melanoma.
Spitler LE
Oncology (Williston Park); 2002 Jan; 16(1 Suppl 1):40-8. PubMed ID: 11829281
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor.
Spitler LE; Grossbard ML; Ernstoff MS; Silver G; Jacobs M; Hayes FA; Soong SJ
J Clin Oncol; 2000 Apr; 18(8):1614-21. PubMed ID: 10764421
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF, sargramostim) administered for 3 years as adjuvant therapy of stages II(T4), III, and IV melanoma.
Spitler LE; Weber RW; Allen RE; Meyer J; Cruickshank S; Garbe E; Lin HY; Soong SJ
J Immunother; 2009; 32(6):632-7. PubMed ID: 19483646
[TBL] [Abstract][Full Text] [Related]
4. Individualized synthetic peptide vaccines with GM-CSF in locally advanced melanoma patients.
Atzpodien J; Fluck M; Reitz M
Cancer Biother Radiopharm; 2004 Dec; 19(6):758-63. PubMed ID: 15665624
[TBL] [Abstract][Full Text] [Related]
5. Systemic therapy for cutaneous melanoma.
Treisman J; Garlie N
Clin Plast Surg; 2010 Jan; 37(1):127-46. PubMed ID: 19914464
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant therapy for malignant melanoma.
Stoutenburg JP; Schrope B; Kaufman HL
Expert Rev Anticancer Ther; 2004 Oct; 4(5):823-35. PubMed ID: 15485316
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant high-dose interferon-alpha therapy for high-risk melanoma.
Kirkwood JM; Tarhini AA
Forum (Genova); 2003; 13(2):127-40; quiz 187-8. PubMed ID: 14732880
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte-macrophage-colony-stimulating factor added to a multipeptide vaccine for resected Stage II melanoma.
Weber J; Sondak VK; Scotland R; Phillip R; Wang F; Rubio V; Stuge TB; Groshen SG; Gee C; Jeffery GG; Sian S; Lee PP
Cancer; 2003 Jan; 97(1):186-200. PubMed ID: 12491520
[TBL] [Abstract][Full Text] [Related]
9. GM-CSF plus antigenic peptide vaccination in locally advanced melanoma patients.
Atzpodien J; Reitz M
Cancer Biother Radiopharm; 2007 Aug; 22(4):551-5. PubMed ID: 17803450
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant therapy of malignant melanoma.
Dickler MN; Coit DG; Meyers ML
Surg Oncol Clin N Am; 1997 Oct; 6(4):793-812. PubMed ID: 9309094
[TBL] [Abstract][Full Text] [Related]
11. Endogenous Heat-Shock Protein Induction with or Without Radiofrequency Ablation or Cryoablation in Patients with Stage IV Melanoma.
Domingo-Musibay E; Heun JM; Nevala WK; Callstrom M; Atwell T; Galanis E; Erickson LA; Markovic SN
Oncologist; 2017 Sep; 22(9):1026-e93. PubMed ID: 28679643
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant therapy for patients with high-risk malignant melanoma.
McClay EF
Semin Oncol; 2002 Aug; 29(4):389-99. PubMed ID: 12170442
[TBL] [Abstract][Full Text] [Related]
13. Cytokine therapy in advanced melanoma.
Kalaaji AN
J Drugs Dermatol; 2007 Apr; 6(4):374-8. PubMed ID: 17668534
[TBL] [Abstract][Full Text] [Related]
14. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
15. [Surgical and adjuvant drug therapy in head and neck cutaneous melanoma].
Hauschild A; Lischner S; Christophers E
Laryngorhinootologie; 2000 Jul; 79(7):428-33. PubMed ID: 11005097
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant application of interferons.
el Kassas H; Kirkwood JM
Semin Oncol; 1996 Dec; 23(6):737-43. PubMed ID: 8970596
[No Abstract] [Full Text] [Related]
17. [Adjuvant and palliative therapy of melanoma. Current status].
Tilgen W
Chirurg; 1994 Mar; 65(3):153-63. PubMed ID: 7514966
[TBL] [Abstract][Full Text] [Related]
18. Phase II multicenter trial of maintenance biotherapy after induction concurrent Biochemotherapy for patients with metastatic melanoma.
O'Day SJ; Atkins MB; Boasberg P; Wang HJ; Thompson JA; Anderson CM; Gonzalez R; Lutzky J; Amatruda T; Hersh EM; Weber JS
J Clin Oncol; 2009 Dec; 27(36):6207-12. PubMed ID: 19917850
[TBL] [Abstract][Full Text] [Related]
19. Multidisciplinary treatment of primary melanoma.
Yao K; Balch G; Winchester DJ
Surg Clin North Am; 2009 Feb; 89(1):267-81, xi. PubMed ID: 19186240
[TBL] [Abstract][Full Text] [Related]
20. Strategies for the development of more effective adjuvant therapy of melanoma: current and future explorations of antibodies, cytokines, vaccines, and combinations.
Kirkwood JM; Moschos S; Wang W
Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2331s-2336s. PubMed ID: 16609054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
